Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 19, 2025, Neovacs SA (ALNEV.PA) has a market cap of $203,196 Dollars USD. According to our data, Neovacs SA is ranked No.9297 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 19, 2025 | $203,196 Dollars |
-35.23%
|
| Dec 31, 2024 | $0.31 M |
-99.49%
|
| Dec 29, 2023 | $61.45 M |
-94.05%
|
| Dec 30, 2022 | $1.03 B |
740.00%
|
| Dec 31, 2021 | $0.12 B |
-98.34%
|
| Dec 31, 2020 | $7.42 B |
-47.93%
|
| Dec 31, 2019 | $14.26 B |
-71.43%
|
| Dec 31, 2018 | $49.89 B |
-55.87%
|
| Dec 29, 2017 | $113.06 B |
-43.21%
|
| Dec 30, 2016 | $199.08 B |
-27.31%
|
| Dec 30, 2015 | $273.88 B |
-4.17%
|
| Dec 31, 2014 | $285.79 B |
-44.70%
|
| Dec 31, 2013 | $516.80 B |
-2.30%
|
| Dec 28, 2012 | $528.98 B |
-34.38%
|
| Dec 30, 2011 | $806.18 B |
46.64%
|
| Dec 30, 2010 | $549.77 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
UK
|
 Sanofi
SNY
|
$124.64 B |
0.327 B
|
France
|
 AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
UK
|
 Pfizer
PFE
|
$125.57 B |
0.001 M
|
USA
|
 Merck
MRK
|
$196.28 B |
0.008 M
|
USA
|
 Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
USA
|
 Novartis
NVS
|
$219.89 B |
0.932 B
|
Switzerland
|
 Moderna
MRNA
|
$9.56 B |
-0.000 M
|
USA
|
 BioNTech
BNTX
|
$23.74 B |
0.000 M
|
Germany
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
 Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
USA
|
 Amgen
AMGN
|
$149.09 B |
0.124 B
|
USA
|
 Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
USA
|
| Market Cap | = | ALNEV.PA Stock Price | * | ALNEV.PA Shares Outstanding |
| = | $0.02 | * | 4.83 M | |
| = | $203,196 Dollars |